Dr. Erlinda Maria Gordon, MD

Expert Publications

• Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic t
• Phase I/II evaluation of safety and efficacy of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct (Md-dnG1) as adjunctive intervention for superficial corneal opacity/corneal scarring.
• First clinical experience using a 'pathotropic' injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer.
• Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype.
• Gene therapy in a murine model for clinical application to multiple sclerosis.
• Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
• Nanotechnology blooms, at last (Review).
• Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
• Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma.
• The 'timely' development of Rexin-G: first targeted injectable gene vector (review).
• Advanced phase I/II studies of targeted gene delivery in vivo: intravenous Rexin-G for gemcitabine-resistant metastatic pancreatic cancer.
• Rexin-G, a targeted genetic medicine for cancer.
• Noteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agent.
• Pathotropic targeting advances clinical oncology: tumor-targeted localization of therapeutic gene delivery.

Clinical Trials

• Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma
• Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma

Media Releases

Get to know Pediatric Hematologist-Oncologist Dr. Erlinda Maria Gordon, who serves patients in Santa Monica, California.

Dr. Gordon is an experienced pediatric hematologist-oncologist, cancer drug developer, biopharmaceutical founder and executive with a proven track record in translational biomedical research, patient care and cancer drug development. Currently, she serves as the Director of Biological and Immunological Therapies and the Chairman of the NIH-approved Institutional Biosafety Committee at the Sarcoma Oncology Center in Santa Monica, California.

The mission of the Sarcoma Oncology Center is to provide the best possible care for all their cancer patients. They promise to support their patients and offer the best possible care regardless of the gravity of their illness. Meeting their patients’ medical and personal needs is their highest priority. They give clear and comprehensive information to help them make informed decisions and participate in their own medical care. They believe that compassion and mutual respect are essential for success in meeting all the dimensions of cancer care.

A native of the Philippines, Dr. Gordon received her medical degree from the University of Santo Tomas Medical College of Medicine and Surgery in 1971. Upon relocating to the United States, she completed her residency in anatomic & clinical pathology with the MetroHealth System in 1974, and her residency in pediatrics at the same educational venue in 1976. Finally, she completed her fellowship in pediatric hematology/oncology at the Case Western Reserve University in 1978.

A Diplomate of the American Board of Pediatric Hematology/Oncology, she was a Tenured Associate Professor for 24 years and is a Professor Emeritus at the USC Keck School of Medicine in Los Angeles, California. There, she licensed the First Academic Vector Production Unit at the Norris Comprehensive Cancer Center, served as its first Medical Director for eight years, and was the Gene Therapy Sponsor for clinical protocols using Targeted Genetic Medicines for Cancer.

Furthermore, Dr. Gordon is the co-founder of two biotechnology companies and is a pioneer in the development of targeted gene therapy products. In her position as FDA liaison for these companies, she gained FDA orphan drug approval and fast track designation for pancreatic cancer, soft tissue sarcoma and osteosarcoma and accelerated approval for Rexin-G, the world’s first targeted genetic medicine for cancer.

Throughout her illustrious career, she has been the co-inventor of more than 150 patents in biomedical research, and patented the first targeted gene delivery system for cancer in the USA, Europe and the Philippines. She has authored more than 100 original peer-reviewed articles and served as Editor-in-Chief of the International Journal of Pediatric Hematology-Oncology, Director of the Red Cell Defects Program and the NIH-funded Comprehensive Hemophilia Center at Children’s Hospital of Los Angeles and the NIH-funded Children’s Oncology Group.

Pediatric oncology is a medical specialty focused on the care of children with cancer. A pediatric hematologist/oncologist is a physician who has special training and experience to diagnose and treat blood disorders and cancers in children, teens, and young adults.

As a testament to her success, Dr. Gordon has been the recipient of the Los Angeles Award for Excellence in Biotechnology Research, the National Institutes of Health Research Career Development Award and NIH/FDA funded grant awards. She was also a nominee for the prestigious Thomas Award for Excellence in Research in 2016.

Recommended Articles

• Cholera and Diarrhea

  How Is Cholera Related to Diarrhea? Cholera is an infection that occurs in the small intestines. It is caused by a bacterium known as Vibrio cholerae. The disease is acquired through the intake of contaminated food or water. When an infected person defecates and then clean water comes into contact...

• Different Types of Anxiety Disorders You Should Know About

  Everyone feels anxious from time to time, but chronic anxiety can adversely impact the quality of your life. While in moderation, anxiety is not a bad thing, but when it becomes intense, it can have serious consequences on your physical health too. Everyone experiences anxiety differently. Some have...

• Does Everyone Have Wisdom Teeth?

  Introduction When a person reaches the ages between 17 to 21, the eruption of wisdom teeth or third molars may take place. However, for some, wisdom teeth do not show up at all. These teeth are called wisdom teeth because they tend to show up at a later and more mature age. When wisdom teeth...

• 5 Tips On Living With Lupus

  Lupus is a chronic, autoimmune disease that can cause harm anywhere in the body. It can manifest in your organs, joints or even skin. When affected by lupus, your immune systems does not work not as intended. Your immune system is supposed to combat bacteria, germs and viruses. The body is protected...

• When to See a Doctor About a Sore Throat

  Both children and adults can be affected by sore throats for a variety of reasons. These include bacteria, allergy, viruses and drainage of a runny nose that can lead to throat pain or discomfort.Sore throat is usually a symptom of an underlying condition. To be able to treat a sore throat, the...

• Not Feeling Quite Right: How Sleep Apnea Affects the Brain

  Sleep apnea has earned a lot of popularity lately. The terrifying disease can cause healthy people to decease unexpectedly during the night. It was certified as one of the causes of Carrie Fisher’s death, the legendary 60-year-old actress who played Princess Leia in the successful movie saga, Star...